Physician profile
Keith C Fleischman
NPI 1184885949
$1,674.11
in general payments reported to CMS, 2019-2025
18 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $110 · 2021: $101 · 2022: $103 · 2023: $209 · 2024: $340 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $363.83 | 2022-2025 | |
| Paragon 28, INC. | $209.87 | 2019-2025 | Additive Orthopedics, Monkey Rings, Precision Mis Bunion |
| Smith+Nephew, INC. | $189.30 | 2019-2024 | Grafix Pl, Collagenase Santyl, Regranex |
| Stryker Corporation | $176.85 | 2019-2025 | Augment Injectable, Flexband, Ortholoc 3di |
| Tactile Systems Technology INC | $168.60 | 2019 | |
| Integra Lifesciences Corporation | $90.87 | 2019-2021 | |
| Organogenesis INC. | $63.71 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $56.74 | 2024-2025 | Nuzyra |
| Abbvie INC. | $50.43 | 2023-2024 | |
| Medtronic, INC. | $49.09 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Grt US Holding, INC. | $45.99 | 2022 | |
| Solventum Corporation | $42.80 | 2024-2025 | Activ.A.C., V.A.C. Veraflo |
| Nevro Corp. | $42.19 | 2019 | |
| Kci USA, INC. | $40.89 | 2019-2022 | |
| Averitas Pharma INC. | $40.36 | 2025 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $16.00 | 2020 | |
| Convatec INC. | $13.42 | 2023 | |
| Merck Sharp & Dohme LLC | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.